Equashield provides manual and automated solutions for compounding and administering hazardous drugs. Its products include EQUASHIELD II, its flagship closed system transfer device (CSTD), and EQUASHIELD Pro, the first ever closed system-enabled automated pharmacy compounding system (APSC).
Equashield is a medical device company that provides closed system transfer devices (CSTD) for the safe handling of hazardous drugs. Its proprietary family of products, which protect healthcare workers from the risks associated with exposure to hazardous drugs and vapours, have applications in compounding in pharmacy to the administration in nursing. Its CE marked and FDA cleared product portfolio includes a wide array of closed syringes and adapters for accessing vials and IV bags in pharmacy as well as a selection of connectors and tubing sets for nursing.
Its products include EQUASHIELD II, its flagship closed system transfer device (CSTD), and Equashield PRO, the first ever closed system-enabled automated pharmacy compounding system (APSC).
The company has an ISO 9001- and ISO 13485-certified, US GMP-compliant production facility equipped with a 3,000 m2 ISO-8 (100,000) class clean-room conducting highly automated in-house production processes including injection moulding, extrusion, ultrasonic forming, laser and UV bonding and blister packaging.
Equashield is privately held and has more than 300 employees.